comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 00:49:31 - browse：1347

President Joe Biden talks in the Roosevelt Room of the White House, in front of a painting of Theodore Roosevelt on a horse back — politics coverage from STAT — President Biden MANDEL NGAN/AFP via Getty Images

WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to undermine patent rights for certain high-priced medicines. It’s an early step that could have major ramifications for the American pharmaceutical industry, depending on whether and how federal officials actually use the authority.

The administration issued a framework for the National Institutes of Health to more broadly use so-called “march-in rights” — a policy that allows it to invalidate patent rights from drugmakers whose products rely on federally funded research. The framework lays out when the agency might assert this authority, and endorse using a drug’s price in that determination.

“We’ll make clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard told reporters. “These authorities are in existing laws, the last administration just didn’t want to allow them to be used in this way.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： FDA moves to stop vape shops from selling Elf Bar, Esco Bars

WSS

Medicare has a new plan to address drug shortages

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Group opposing PBM reform sets lobbying record

Why hospitals are withdrawing from US News rankings

Naloxone nonprofit donates 200,000 doses after FDA approval

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

focus

comprehensive

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

In early work, researchers turn to CRISPR to treat Alzheimer's

The high cost of giving birth even with insurance

What to know about Virgin Galactic's 1st mission taking paying customers to space

ChatGPT in medicine: STAT answers readers' burning questions

How Medicaid coverage policies for immigrants impact new moms

Guidelines to prevent youth baseball injuries need more muscle

Biden tests positive for Covid

Dobbs anniversary: the lost opportunity of abortion as health care

How to use technology to prevent future drug shortages

explore

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Police still searching for prisoner who escaped from NYC hospital

In early work, researchers turn to CRISPR to treat Alzheimer's

As digital health tech proliferates, a new institute aims to cut through hype

A biotech analyst on neuroscience, placebo effect, not over

How dance can help nurses traumatized by Covid

leisure time

hotspot

explore

hotspot